Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
How Care Works
Virtual & Home Visits
Virtual care across 40 states + house calls in Philadelphia
Concierge vs. Direct Care
Zero visit copays, zero hidden fees, relationship model
Send Medical Records
Securely upload prior labs & notes before consultation
Common Questions (FAQ)
PCP scope, insurance, labs & cancellation policies
Services
Primary Care & Acute Visits
Same-day sick visits, refills & comprehensive PCP care
Chronic & Complex Care
POTS, MCAS, Long COVID, Lyme & fatigue workups
Hormones & Endocrine
TRT, thyroid, perimenopause, menopause & PCOS
Metabolic Health & Weight
Advanced lipid testing, GLP-1s & glucose monitoring
Longevity & Prevention
Medicine 3.0 baselines, VO2 max, DEXA & prevention
All Clinical Services
Comprehensive catalogue of 36+ clinical services
Membership
Membership Details
Unlimited direct access, continuous physician care
Care Packages
The Reset & Strategic Roadmap evaluations
Billing & Payment FAQ
HSA/FSA eligibility, transparent cancellation policy
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
Clinical Library & Articles
Evidence-based health guides reviewed by Dr. Ash
What People Say
124 patient reviews across 6 platforms
Contact Dr. Ash
Reach out with questions or book an intro
Patient PortalStart Intake
Insulin Resistance at a Normal Weight
Fishtown Medicine•12 min read

Insulin Resistance at a Normal Weight

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated August 16, 2026
On This Page
  • What did the study find?
  • Can you have insulin resistance at a normal weight?
  • Your Personal Fat Threshold and the ReTUNE Trial
  • Why do standard BMI charts fail South Asian and East Asian adults?
  • Why does a regular checkup miss this?
  • Guidance from the Clinic
  • What should you check, and what do the numbers mean?
  • How do you reverse normal-weight insulin resistance without starving yourself?
  • When should you get this checked sooner?
  • Common Questions
  • Can you be insulin resistant without being overweight?
  • What is HOMA-IR?
  • Does a normal A1c rule out insulin resistance?
  • What fasting insulin level is optimal?
  • At what age should adults get screened for insulin problems?
  • Is insulin resistance reversible?
  • Do I need to fast for these tests?
  • Does this study apply to people over 44?
  • Deep Questions
  • Why does insulin rise years before glucose does?
  • What does an R-squared of 0.23 mean for BMI and insulin resistance?
  • If HOMA-IR is only an estimate, why is it used at all?
  • Why did insulin resistance fall in men but not women during the study period?
  • How should family background change what gets measured?
  • Does exercise help even if body weight does not change?
  • Why measure waist circumference if BMI is already known?
  • What does the diet finding mean for what I eat?
  • Should I ask for a continuous glucose monitor?
  • What happens if insulin resistance goes unaddressed?
  • ✦Key Takeaways
  • Related at Fishtown Medicine
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR30-second take

Yes, you can have insulin resistance at a normal weight with a normal A1c. In a national study of 6,247 adults aged 18 to 44 without diabetes, 4 in 10 had insulin resistance, and close to half of those were not obese. Fishtown Medicine measures fasting insulin alongside glucose, because insulin climbs years before blood sugar changes.

TL;DR: Insulin is the hormone that moves sugar out of your blood and into your cells. When your cells stop answering it well, that is insulin resistance, and it can build for years before your blood sugar looks wrong. A national study of 6,247 adults aged 18 to 44, none of them diabetic, found that about 4 in 10 had insulin resistance. Close to half of those people were not obese. A regular checkup often misses this, because the 2 tests it leans on change late, and because the screening rules start at age 35 and only apply if your BMI is 25 or higher. To find out where you stand, ask for a fasting insulin level with your next bloodwork, and bring the result to a doctor who will read it next to how you feel and what else is on the panel.

Everyone in this study had blood sugar in the normal range. That was the entry requirement. Researchers took 6,247 adults between 18 and 44 from a national health survey, removed anyone with diabetes or known heart disease, and measured what was left. About 4 in 10 of them had insulin resistance.

If your bloodwork came back fine and you are young enough that nobody suggested looking further, that number is the argument for looking anyway. The tests in a standard checkup are built to catch this problem once it has arrived. Insulin resistance arrives years earlier, and it can be measured the whole time it is building.

What did the study find?

About 4 in 10 young adults without diabetes had insulin resistance, and the number barely moved across 12 years.

The work comes from the National Health and Nutrition Examination Survey, the long-running federal program that examines a representative slice of the country in mobile clinics. Researchers pooled 6 survey cycles from 2007 through 2018 and looked at adults 18 to 44 who had no diabetes and no known cardiovascular disease. Insulin resistance was 44.8% in the 2007 to 2010 group and 40.3% in the 2015 to 2018 group, a decline too small to call a trend. Among men it did fall, from 50.2% to 41.0%. Among women it held steady near 39.5%.

The measure they used is called HOMA-IR, which stands for homeostatic model assessment of insulin resistance. It is arithmetic performed on 2 fasting numbers, your glucose and your insulin, and it estimates how hard your pancreas is working to hold your blood sugar where it is. This study counted a HOMA-IR of 2.5 or higher as insulin resistance. That threshold is the study's own research definition, built for sorting a population. What an individual number means depends on the person it came from.

Thin on the Outside, Insulin Resistant on the Inside: Personal Fat Threshold, MASALA Cutoffs, 4-Marker Panel, and Reversal Blueprint

Can you have insulin resistance at a normal weight?

Yes. Roughly 1 in 4 normal-weight American adults (BMI 18.5 to 24.9) are metabolically unhealthy, and close to half of the young adults with insulin resistance in the national NHANES study were not obese.

Doctors call this pattern MONW (metabolically obese normal weight), or "thin on the outside, fat on the inside." In the NHANES study, people with insulin resistance were more likely to have a BMI of 30 or above (56.6% versus 14.7%), so body size still matters. Yet when researchers compared insulin resistance against whole-body DEXA scans, total BMI and regional fat each explained only a fifth to a quarter of the person-to-person difference.

Why can two people stand at the same height and weight, with a BMI of 22, while one has clear arteries and the other has fatty liver and prediabetes? The answer comes down to two physiological rules: your personal fat threshold and adipose tissue expandability.

Your Personal Fat Threshold and the ReTUNE Trial

Think of subcutaneous fat - the pinchable fat under the skin of your hips, thighs, and buttocks - as a safe storage tank. Large genetic studies (Lotta et al., Nature Genetics 2017) show that dozens of gene variants control how easily you can recruit new, small fat cells in your lower body when you eat extra calories.

If you inherited a large safe storage tank, you can gain 40 or 50 pounds and reach a BMI of 34 while keeping almost all of that energy safely tucked under the skin. If you inherited a small safe tank, your hip and thigh fat cells fill up at a BMI of 21 or 22. Once that safe tank hits its ceiling, swollen fat cells become inflamed, drop their protective hormone (adiponectin), and spill free fatty acids into the bloodstream. That spillover settles inside your abdomen (visceral fat), your liver, and your pancreas.

Inside liver cells, those spilled fats form molecules called diacylglycerols (DAG) and ceramides. As Gerald Shulman showed in The New England Journal of Medicine, DAG activates an enzyme (PKC-epsilon) that gums up the liver's insulin receptor. Even when your pancreas floods the bloodstream with insulin, the liver cannot hear the signal, so it keeps pouring extra sugar into your blood all night.

Roy Taylor proved this in the ReTUNE trial (Clinical Science 2023). He enrolled adults who developed type 2 diabetes despite having a normal or near-normal BMI (21 to 27 kg/m²). MRI scans showed their liver fat was 3 times higher than normal even though they looked lean in clothes. When they lost just 6.5 kg (about 5% to 10% of their body weight, shifting average BMI from 24.8 down to 22.5), liver and pancreas fat cleared out and 70% put their diabetes into full remission. They were never "too heavy" by a textbook chart. They had simply crossed their personal fat threshold.

Why do standard BMI charts fail South Asian and East Asian adults?

Standard BMI cutoffs were built on European-descent populations and miss more than a third of metabolic disease in Asian adults.

At the same body-fat percentage, South Asian and East Asian adults carry a BMI roughly 2 to 3 points lower than White adults. In a landmark diabetes screening study (Araneta et al., Diabetes Care 2015), waiting until a BMI of 25 missed 36% of undiagnosed diabetes in Asian Americans (sensitivity 63.7%). Lowering the screening trigger to BMI 23 caught 84.7% of cases, which is why the American Diabetes Association, the World Health Organization, and the US Preventive Services Task Force now set BMI 23.0 as the overweight cutoff for Asian adults.

In the MASALA study of South Asian Americans and national NHANES analyses (Aggarwal et al., Annals of Internal Medicine 2022), the gap is even sharper:

  • Equivalent diabetes risk at BMI 19.6 to 20.0: A South Asian adult at a BMI of 19.6 carries the same diabetes prevalence as a White adult at a BMI of 25.0.
  • 44% abnormal at normal weight: Nearly 44% of normal-weight South Asians have metabolic dysfunction, compared with 21% of normal-weight White adults.
  • More liver and muscle fat at lower weight: CT body-composition scans (Shah et al., International Journal of Obesity 2016) show that South Asians carry significantly more liver fat, more fat marbled inside muscle, and less total skeletal muscle than White, Black, Latino, or Chinese American adults despite a lower BMI.

Because scale weight hides abdominal fat, we pair ethnic-specific BMI with two tape-measure checks you can run at home:

  1. Waist-to-Height Ratio under 0.5: Your waist circumference (measured at the belly button) should be less than half your height, regardless of race or sex.
  2. Ethnic-specific waist ceilings: For South Asian and East Asian adults, metabolic risk climbs above 90 cm (35.4 inches) in men and 80 cm (31.5 inches) in women, compared with 102 cm (40 in) and 88 cm (35 in) in European-descent charts. Read our full South Asian Cardiometabolic Playbook for the complete family-risk workup.

Why does a regular checkup miss this?

Because hemoglobin A1c and fasting glucose only turn abnormal after years of pancreatic overtime, missing roughly 3 out of 4 insulin-resistant adults.

In a gold-standard insulin clamp study of lean Asian adults with a BMI of 22 (Ding et al., AJP Endocrinology and Metabolism 2018), insulin-resistant participants had 2 times more visceral fat, 4 times more liver fat, 20% to 30% worse muscle glucose clearance, and 65% higher post-meal insulin levels than healthy peers of the same BMI. Yet their fasting blood glucose and hemoglobin A1c were identical.

In the multicenter IRAS cohort (Lorenzo et al., Diabetes Care 2010), using prediabetes A1c cutoffs (5.7% to 6.4%) caught only 23.6% of clamp-proven insulin-resistant adults - missing 76.4% of people whose pancreas was still working overtime to keep blood sugar down.

Dr. Ash puts it to patients this way on calls: A1c is a fine test if you already have diabetes. If you do not, you want an insulin level, because you want to know before that problem happens.

Guidance from the Clinic

Dr. Ash
"A normal result tells you what that test was built to find. It does not tell you that nothing is happening. When somebody is 34, runs three days a week, has a BMI of 22.5, and still crashes after lunch or sees their triglycerides climbing, the useful question is what nobody has measured yet."

What should you check, and what do the numbers mean?

Instead of relying on A1c alone, a five-marker panel exposes hidden visceral and liver fat years before blood sugar rises.

MarkerStandard Lab "Normal"Fishtown Preventive TargetWhy It Catches Lean Insulin Resistance
Fasting Insulin< 18 to 25 uIU/mL3 to 6 uIU/mL (> 9 is high; HOMA-IR < 1.5)Measures pancreatic effort directly. Values of 1 to 2 can signal underfueling in heavy trainers; 10 to 15 is hidden compensation.
Triglyceride-to-HDL RatioNot reportedUnder 1.5 (Under 2.0 max)Best insulin-free blood clue. In normal-weight adults, a TG/HDL ratio of 3.0 or higher triples the odds of insulin resistance (Pantoja-Torres 2019).
ALT (Liver Enzyme)< 40 to 50 IU/LUnder 23 IU/LUp to 60% of fatty liver hides inside lab "normal." On 3T MRI liver scans (Martin-Rodriguez 2017), an ALT above 23 IU/L identifies early liver fat with 93% accuracy.
ApoB< 100 to 130 mg/dLUnder 70 mg/dL (< 60 if high risk)Counts every plaque-forming particle. Insulin resistance packs cholesterol into small, dense particles that standard LDL misses (Sierra-Johnson 2007).
DEXA Visceral Fat & ALMINot orderedVAT < 100 cm² (< 1.0 lb)** + **ALMI > 50th percentileMeasures abdominal visceral fat and arm/leg muscle mass directly so you know whether you need more muscle, less visceral fat, or both.

The full reasoning behind our blood targets lives on metabolic health beyond A1c. When fasting insulin or the TG/HDL ratio comes back high, a continuous glucose monitor for 2 weeks shows how your glucose behaves around your own meals, workouts, and sleep. You can also see how we read reference ranges in how to read your lab results and the tests most annual panels leave out.

How do you reverse normal-weight insulin resistance without starving yourself?

By expanding your skeletal muscle glucose sink with strength training and draining liver and visceral fat - neither of which requires losing scale weight if you are already lean.

To be direct about the evidence boundary: no 10,000-person randomized trial has enrolled only lean insulin-resistant adults for a multi-year exercise outcome study. What we do have are mechanism trials, MRI liver studies, and smaller body-recomposition trials that show why chasing a lower number on the bathroom scale is the wrong goal when your BMI is already 21 or 22:

  1. Build the muscle glucose sink (strength training 2 to 4 days/week): Skeletal muscle clears roughly 80% of insulin-stimulated blood sugar. In a classic randomized trial (Holten et al., Diabetes 2004), adults trained only one leg for 6 weeks while leaving the other leg untrained. Whole-body weight stayed the same, yet the trained leg increased its GLUT4 glucose transporters by 40%, boosted insulin signaling proteins, and cleared significantly more blood sugar than the untrained leg in the same body. In a 10-week resistance circuit study of normal-weight-obese women, strength training alone moved 50% of participants out of the metabolically unhealthy category without dieting. Because the acute glucose boost from a workout fades after 48 to 72 hours, spacing sessions across the week matters more than marathon weekend workouts.
  2. Drain liver and visceral fat at zero weight loss: You do not have to lose pounds on the scale to empty fat out of your liver and abdomen. In Robert Ross's landmark Annals of Internal Medicine trial, men who exercised daily while eating back 100% of their burned calories (zero scale weight loss) still significantly shrank their MRI-measured visceral fat. Even better, a 2023 meta-analysis of MRI liver trials by Stine et al. proved that exercise training makes adults 3.5 times more likely to cut liver fat by 30% or more even without weight loss.
  3. Use a modest 5% trim only if you crossed your personal fat threshold: If your BMI moved from 20 in college to 24.5 in your late 30s and your waist grew 2 inches, a gentle 5% weight reduction (8 to 12 pounds) while lifting weights and eating 1.6 g/kg of protein is remarkably potent. In a study of lean metabolically unhealthy adults (Chooi et al., Obesity 2018), a 5% weight trim cut liver fat in half (by 50%), trimmed visceral fat by 11%, and improved clamp-measured insulin sensitivity by 21% to 26%.

That sequence - muscle first, sleep and stress second, protein and starch timing third, and targeted medication only when needed - is laid out in the metabolic health pillar and metabolic flexibility.

When should you get this checked sooner?

Use these If -> Then rules to decide whether to run the full panel now:

  • If you are of South Asian, East Asian, Filipino, or Latino heritage and your BMI is 23 or higher (or your waist-to-height ratio is 0.5 or above) -> Then order fasting insulin, HbA1c, lipid panel (TG/HDL), ApoB, Lp(a), and ALT now instead of waiting for age 35 or BMI 25.
  • If your A1c is "normal" (under 5.7%) but your TG/HDL ratio is above 2.0 or your ALT is above 23 IU/L -> Then add a fasting insulin draw and consider a DEXA body composition scan to check visceral fat and muscle mass.
  • If you have PCOS, a history of gestational diabetes, or a parent with type 2 diabetes or early heart disease -> Then check fasting insulin and ApoB in your 20s or 30s regardless of how lean you look.
  • If an earlier panel already put you in the prediabetes range -> Then read reversing prediabetes for our step-by-step protocol.

Separately, some symptoms need care now instead of a scheduled workup. Excessive thirst with frequent urination, unexplained weight loss, blurred vision, or persistent nausea and vomiting can signal blood sugar that is already high, and those belong in a same-day visit or an emergency department. Chest pain, shortness of breath at rest, or one-sided weakness are emergencies regardless of what any lab said last month.

✦

Key Takeaways

  1. Roughly 1 in 4 normal-weight adults (BMI 18.5 to 24.9) are metabolically unhealthy (MONW), and in a national NHANES study of 6,247 young adults without diabetes, 4 in 10 had insulin resistance.
  2. Your personal fat threshold sets how much fat your hip and thigh skin can safely hold before energy spills into your liver and pancreas; in the ReTUNE trial, losing just 6.5 kg cleared liver fat and reversed diabetes in 70% of normal-BMI patients.
  3. Standard BMI cutoffs miss 36% of undiagnosed diabetes in Asian Americans; screening should start at BMI 23 (with equivalent diabetes risk appearing at BMI 19.6 to 20.0 in South Asians) alongside a waist-to-height ratio under 0.5.
  4. Hemoglobin A1c alone misses 76% of early insulin resistance; a 5-marker check (fasting insulin 3 to 6 uIU/mL, TG/HDL ratio under 1.5, ALT under 23 IU/L, ApoB under 70 mg/dL, and DEXA visceral fat) catches it years earlier.
  5. You do not need to lose scale weight to reverse lean insulin resistance: strength training boosts muscle GLUT4 glucose transporters by 40%, and exercise is 3.5 times more likely to cut liver fat by 30% or more even at zero weight loss.

Related at Fishtown Medicine

  • 9-System Biomarker Reference Guide: Optimal vs Standard Lab Ranges - lookup table for fasting insulin, HOMA-IR, TG/HDL, ALT, ApoB, and every core marker
  • Health for South Asians: Cardiometabolic Playbook - why standard BMI lies, MASALA study data, and the full family-risk workup
  • Metabolic Health Beyond A1c - the tests we track instead of blood sugar alone, and the targets we use
  • Understanding Insulin Resistance - what it is, what drives it, and how it gets treated
  • The Tests Most Annual Panels Leave Out - the markers that move a prevention plan
  • What Your Lab Results Mean - reference ranges, flags, and what a normal result can and cannot say
  • Continuous Glucose Monitoring in Philadelphia - what 2 weeks of your own data shows
  • The Metabolic Health Pillar - the whole framework this page is one way into
  • CGMs and Glucose Optimization - reading your own glucose patterns

Scientific References

  1. Parcha V, Heindl B, Kalra R, Li P, Gower B, Arora G, Arora P. "Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANES." The Journal of Clinical Endocrinology and Metabolism. 2022;107(1):e25-e37. Journal
  2. Taylor R, Barnes AC, Hollingsworth KG, et al. "Aetiology of Type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis (ReTUNE)." Clinical Science. 2023;137(16):1333-1346. PubMed
  3. Lotta LA, Gulati P, Day FR, et al. "Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance." Nature Genetics. 2017;49(1):17-26. DOI
  4. Shulman GI. "Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease." New England Journal of Medicine. 2014;371(12):1131-1141. DOI
  5. Araneta MRG, Kanaya AM, Hsu WC, et al. "Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes." Diabetes Care. 2015;38(5):814-820. PubMed
  6. Gujral UP, Vittinghoff E, Mongraw-Chaffin M, et al. "Cardiometabolic Abnormalities Among Normal-Weight Persons From Five Racial/Ethnic Groups in the United States (MASALA and MESA)." Annals of Internal Medicine. 2017;166(9):628-636. PubMed
  7. Ding C, Chan Z, Chooi YC, et al. "Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes." American Journal of Physiology-Endocrinology and Metabolism. 2018;315(4):E536-E546. PubMed
  8. Lorenzo C, Wagenknecht LE, Hanley AJG, et al. "A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS)." Diabetes Care. 2010;33(9):2104-2109. PubMed
  9. Martin-Rodriguez JL, Gonzalez-Cantero J, Gonzalez-Cantero A, et al. "Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy." Medicine. 2017;96(17):e6770. PubMed
  10. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JFP, Dela F. "Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes." Diabetes. 2004;53(2):294-305. PubMed
  11. Stine JG, Di Joseph K, Pattison Z, et al. "Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Weight Loss: A Systematic Review and Meta-Analysis." American Journal of Gastroenterology. 2023;118(7):1204-1213. PubMed
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique history, labs, and goals. Consult Dr. Ash or your own physician to determine if this approach is right for you, including if you have chronic conditions or take prescription medications.
Ashvin Vijayakumar MD (Dr. Ash)

Fishtown Medicine | Metabolism

2418 E York St, Philadelphia, PA 19125·(267) 360-7927·hello@fishtownmedicine.com·HSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

Yes. In a national study of adults 18 to 44 without diabetes, close to half of those who had insulin resistance were not obese by BMI. Body measurements including BMI, waist circumference, and DEXA-measured fat mass each explained only about a fifth to a quarter of the difference in insulin resistance between people. Fishtown Medicine measures fasting insulin regardless of body size for this reason.
HOMA-IR stands for homeostatic model assessment of insulin resistance. It is a calculation that combines a fasting glucose and a fasting insulin into one number estimating how much insulin your body needs to keep blood sugar steady. Research studies commonly use a cut point such as 2.5 to define insulin resistance across a population. For an individual patient, Fishtown Medicine reads the fasting insulin value itself alongside glucose, symptoms, and the rest of the panel.
No. Hemoglobin A1c reports average blood sugar over roughly 3 months, and blood sugar is what a healthy pancreas protects longest by producing extra insulin. Every participant in this study had normal blood sugar by definition, and 4 in 10 still had insulin resistance. A normal A1c rules out diabetes at that moment. It does not rule out the years of compensation that come first.
Fishtown Medicine uses a preventive target of 3 to 6 uIU/mL for fasting insulin, with 6.1 to 9 read as borderline high and 9.1 or above read as high. The floor exists for a clinical reason, since values of 1 to 2 often accompany underfueling and heavy training. Standard laboratory reference ranges do not flag a result until roughly 18 to 25, which is why an unflagged value can still be worth acting on.
National guidelines from the US Preventive Services Task Force recommend screening for prediabetes and type 2 diabetes starting at age 35, and only for adults who are overweight or obese. Fishtown Medicine measures fasting insulin earlier than that and without a BMI requirement, because the study evidence shows insulin resistance is common in adults from 18 to 44 and frequently present at a normal body weight.
Often, yes, and it responds to the same measures whether or not weight changes. Building muscle through resistance training increases where glucose can be stored and spent, aerobic exercise improves how sensitive cells are to insulin, and adequate sleep affects insulin sensitivity within days. Individual results vary, and someone with a strong family history may need medication alongside those measures. The point of measuring early is that these levers work better before a diagnosis exists.
Yes, for the insulin and glucose portion. A fasting insulin and fasting glucose generally require 8 to 12 hours without food, and water is fine. A1c does not require fasting. Fishtown Medicine schedules the draw so a single morning visit covers the panel.
The study population was 18 to 44, so its prevalence numbers describe young adults specifically. Insulin resistance becomes more common with age, so the findings do not suggest older adults are less affected. What the study adds is evidence that the problem is already widespread well before the age at which screening guidelines begin.

Deep-Dive Questions

Because insulin is the compensation and glucose is the failure. As muscle, liver, and fat cells respond less to insulin, the pancreatic beta cells increase output to hold blood sugar in the normal range, and for years they succeed. A fasting glucose taken during that period is normal and correctly reports that the system is compensating. Fasting insulin measures the size of the compensation, which is why it changes first.
It means body mass index accounted for roughly 23% of the variation in HOMA-IR across the people studied, leaving about 77% attributable to other factors. The other body measures in the study performed similarly, ranging from about 0.14 to 0.24. A relationship that strong is worth taking seriously, and a relationship that leaves three quarters of the variation unexplained is a poor basis for deciding who to test.
Because the reference standard is impractical outside research. The hyperinsulinemic-euglycemic clamp involves controlled infusions over several hours and trained staff, and it correlates strongly with HOMA-IR, which requires one fasting blood draw. Large population studies use HOMA-IR for feasibility. Its known weaknesses include reflecting hepatic insulin resistance more than peripheral muscle insulin resistance, and varying with the insulin assay a laboratory uses.
The study did not determine the cause, and the authors list possible contributors without claiming an answer. They cite documented differences in visceral and liver fat between sexes, hormonal influences on insulin sensitivity, and evidence that adherence to physical activity guidelines improved more among men over the same period. Social and structural factors including healthcare access and health education may also contribute. The finding is best read as a signal that prevention efforts have not reached everyone equally.
It should make you readier to measure early. In this study, prevalence differed across racial and ethnic groups, with the highest rates among Mexican American participants, and the authors point to social and structural determinants of health as the main drivers. Nothing about any group's biology explains them. A separate limitation runs the other way: because HOMA-IR weights liver insulin resistance, it may understate the problem in Black adults. Both points argue for measuring earlier in anyone whose family or background carries higher risk.
Yes, and this is one of the better-established points in the field. A single session of moderate exercise increases glucose uptake into muscle through a pathway that does not depend on insulin, and regular training increases muscle mass, which enlarges the tissue available to store glucose. Improvements in insulin sensitivity are measurable without meaningful weight change. For someone already at a normal weight with insulin resistance, this is the most direct lever available.
Because they measure different things, and waist adds information about where fat is distributed. BMI is weight scaled to height, and it cannot distinguish muscle from fat or abdominal fat from fat elsewhere. Waist circumference approximates abdominal and visceral fat, which is the depot most associated with insulin resistance and cardiovascular risk. In this study waist circumference performed slightly better than BMI, and both left most of the variation unexplained.
It means a crude score could not separate the 2 groups, and it should not be read as evidence that eating does not matter. The measure was a 5-point scale built from 2 days of recorded intake, and it rated the diet poor in roughly 4 of 5 young adults whether or not they had insulin resistance. When almost everyone scores poorly, the score loses its ability to discriminate. Randomized trials of specific dietary changes remain the better evidence for what to do about food.
It depends on what the fasting numbers show. A continuous glucose monitor reveals how your glucose responds to your own meals, exercise, sleep, and stress, which a single fasting value cannot show. Fishtown Medicine generally considers a monitor when fasting insulin is above the target range, when symptoms and labs disagree, or when someone wants to see how their own patterns respond to a change they are making.
The trajectory studied most is progression toward prediabetes and type 2 diabetes, alongside the cardiovascular risk factors that cluster with it. Longitudinal research links insulin resistance in early adulthood with atherosclerotic cardiovascular disease later in life. The NHANES study here is cross-sectional and cannot prove that progression on its own, and it documents the clustering that makes the question worth asking decades earlier than most people are asked it.

Ready when you are

Start your intake

The chat is our AI assistant, answering from our published guides. To talk it through with Dr. Ash himself, start with the intake.

Related Intelligence

Metabolic Health

Metabolic Health

Why you feel tired at 3 PM, and how to fix it - insulin resistance, glucose swings, and the metabolic testing that catches dysfunction early.

Read Deep Dive
Your Relationship With Yourself: The Ground of Every Health Change | Fishtown Medicine

Your Relationship With Yourself: The Ground of Every Health Change | Fishtown Medicine

The relationships that shape your health reach beyond other people. The first one is with yourself: the story you tell, whether you choose yourself, and how you talk to yourself when it is hard. Why that relationship decides whether a health change sticks, from Fishtown Medicine in Philadelphia.

Read Deep Dive
Performance Physical Philadelphia: 4 Tests That Predict How You Age

Performance Physical Philadelphia: 4 Tests That Predict How You Age

A performance physical measures how well you are aging: VO2 max, grip strength, mobility, and body composition - the 4 tests that predict healthspan.

Read Deep Dive

New patients

Talk it through with Dr. Ash.

Share your numbers if you know them, your family history, and what you want to get ahead of. Dr. Ash reads every intake personally.

HSA/FSA eligible
No initiation or cancellation fees
No copays
Tell Dr. Ash what’s going on →
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
2418 E York St, Philadelphia, PA 19125(267) 360-7927Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health LiteracyClinical Evidence & Research

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical IndependenceCare NetworkResearch & Monographs